An experimental treatment for ALS will get its day before the FDA this week—but the agency is unconvinced it works

“FDA is the 800-pound gorilla here, and if they’re convinced that the drug doesn’t work, it’s very hard to change their minds,” Marc Scheineson, a former associate FDA commissioner who now consults for drugmakers, told the Associated Press. Read More